In vitro susceptibility of Entamoeba histolytica to fluoroquinolones, nitrofurans and other antiamebic agents.
Cedillo-Rivera
R
R
Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Hospital de Pediatria, Centro Médico Nacional Siglo XXI, IMSS, México, D.F., Mexico.
Tapia-Contreras
A
A
Torres
J
J
Muñoz
O
O
D000081:Acetamides / Q000627:therapeutic use; D000563:Amebicides / Q000627:therapeutic use*; D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D004748:Entamoeba histolytica / Q000187:drug effects*; D024841:Fluoroquinolones; D009581:Nitrofurans / Q000627:therapeutic use*; D009593:Nitroimidazoles / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use
D000081:Acetamides; D000563:Amebicides; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009581:Nitrofurans; D009593:Nitroimidazoles; D011804:Quinolines; C010151:etofamide; C026546:quinfamide; C052587:4-nitroimidazole